The past decades have witnessed tremendous progress in the detailed structural knowledge of proteins as potential or validated drug targets and the discovery of new drugs based on this wealth of knowledge progressed in parallel [...].
Gemma, S. (2020). Structure-Based Design of Biologically Active Compounds. MOLECULES, 25(14) [10.3390/molecules25143115].
Structure-Based Design of Biologically Active Compounds
Gemma, Sandra
2020-01-01
Abstract
The past decades have witnessed tremendous progress in the detailed structural knowledge of proteins as potential or validated drug targets and the discovery of new drugs based on this wealth of knowledge progressed in parallel [...].
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
molecules-25-03115.pdf
accesso aperto
Descrizione: Editorial
Tipologia:
PDF editoriale
Licenza:
Creative commons
Dimensione
146.82 kB
Formato
Adobe PDF
|
146.82 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/11365/1279086